{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-068526","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.875985+00:00","generated_at":"2026-06-01T06:15:14.691545+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"DarioHealth appoints Steven Nelson as CCO; President Richard Anderson departs","bullets":["Steven Nelson, formerly CEO of Contigo Health (Premier Inc.), named Chief Commercial Officer effective June 5, 2024.","Nelson receives $400,000 base salary, annual bonus up to $400,000 tied to GAAP revenue targets (targets redacted).","Nelson granted time-vesting option for 500,000 shares and performance options for up to 400,000 (2024) and 450,000 shares (2025-2027) vested on revenue milestones.","President Richard Anderson mutually agreed to step down; no disagreement; will stay as consultant and Advisory Board member.","Anderson's departure not related to any disagreement with company's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-068526","json":"https://secwatch.observer/filing/0001104659-24-068526.json","markdown":"https://secwatch.observer/filing/0001104659-24-068526.md","text":"https://secwatch.observer/filing/0001104659-24-068526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924068526/0001104659-24-068526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924068526/tm2416414d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:15:14.691545+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c01b8a81e","claim":"Richard Anderson departed as President at DarioHealth Corp..","evidence_excerpt":"the Company and Richard Anderson, the Company’s President, mutually agreed for Mr. Anderson to cease serving in his role as President of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924068526/0001104659-24-068526-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"President"}]},{"claim_id":"692e8d5c99","claim":"Steven Nelson was appointed as Chief Commercial Officer at DarioHealth Corp..","evidence_excerpt":"appointed Steven Nelson, age 51, to serve as its Chief Commercial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924068526/0001104659-24-068526-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Commercial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}